S_nary Adeno-associated virus (AAV) is well known for suppression of oncogenesis in rodents, but its inhibitory effects on human carcinoma are less well understood. We report the differential ability of AAV to inhibit the tumorigenicity of two human cervical carcinoma cell lines. The wild-type AAV-2 DNA carried by a pSV2Neo vector was transfected into HeLa cells, which contain 50 copies of human papillomavirus type 18 (HPV-18), and SiHa cells, which contain 1-2 copies of HPV-16. About 1-3 copies of AAV genome were introduced per cell. AAV transfection moderately reduced the growth rate and anchorage-independent activity of the cells. In nude mice, the size of tumours arising from SiHa cells was reduced by 87%, in contrast to no reduction in tumour size arising from HeLa cells. This suggests that the differential suppression exerted by AAV may be due to differences in HPV copy number. To define the region that is responsible for the oncosuppression, mutation analyses were conducted. The results of nude mice assays showed that both the replication gene and inverted terminal repeats of AAV were important for the inhibition. This study may provide a model system for further studies on the underlying mechanism of AAV oncosuppressive activity.
The parvoviridae family has been divided into three genera based on the requirement for helper viruses. Autonomous parvovirus and densovirus replicate autonomously, whereas dependovirus needs a helper virus for replication (Siegl et al., 1985) . Autonomous virus and dependovirus interfere with both spontaneous oncogenesis and experiment-induced tumours in rodents (Rommelaere and Tattersall, 1990 ). The suppression is probably exerted through indirect, e.g. immune system or direct virus-host interactions (van Pachterbeke et al., 1993) . The underlying mechanism is however still elusive.
Adeno-associated virus (AAV), a dependovirus, significantly inhibits carcinogenesis induced by adenovirus (Ad), herpes simplex virus, bovine papillomavirus (BPV) and the ras oncogene in rodents (Schlehofer, 1994) . In humans, no known disease has been associated with AAV infection (Berns and Bohensky, 1987) , although recent reports have shown a linkage of AAV infection to miscarriage in mice and humans (Botquin et al., 1994; Tobiasch et al., 1994) .
Studies of the effects of AAV on human cancer cells have led to four main conclusions. (1) AAV infection reduces human tumour cell proliferation (Bantel-Schaal, 1990 ), disturbs the cell cycle (Winocour et al., 1988) and induces cell differentiation (Bantel-Schaal, 1995;  Klein-Bauernschmitt et al., 1992) . (2) Seroepidemiological studies have found that the incidence of AAV antibody are lower in cervical or prostate carcinoma patients than in controls (Georg-Fries et al., 1984; Mayor et al., 1976) . (3) AAV infection has been reported to suppress the promoter activity of human papillomavirus type 16 (Hermonat, 1994) , while HPV is one of the potent inducers of cervical carcinoma (zur Hausen, 1994) . (4) AAV infection inhibits in vitro cellular transformation of rodent cells mediated by BPV, which is a close relative to HPV (Hermonat, 1989) . Taken together, it seems that AAV infection is reciprocally related to human cervical carcinoma. However, the inhibitory activity of AAV in human cells is less well understood than rodents. Nude mice assay has shown that the tumour growth rate induced by human cervical carcinoma HeLa cells was moderately reduced by AAV infection (Walz and Schlehofer, 1992) . The issue of whether AAV can suppress the tumorigenicity of human cervical carcinoma cells was thus pursued in this study.
The human AAV type 2 DNA was cloned into a pSV2Neo vector (Southern and Berg, 1982) to generate a pAVNeo plasmid. The pSV2Neo or pAVNeo DNA was transfected into two cervical carcinoma cell lines, HeLa and SiHa. HeLa contains 10-50 copies of HPV-18 DNA (Schwarz et al., 1985) per cell and SiHa contains 1-2 copies of HPV-16 DNA (Baker et al., 1987) per cell. The cells were selected by geneticin and expanded without cloning to avoid possible misleading conclusions derived from using a particular cloned cell. A mixed culture is also more similar to the in vivo condition than a cloned one. To assess whether the tumorigenicity of carcinoma cells can be affected by AAV transfection, a nude mouse assay was performed. The in vitro transformation properties including growth rate and anchorage-independent activity were compared in cells transfected with or without AAV. The AAV genome consists of a replication (rep) gene, a capsid (cap) gene and two palindromic inverted terminal repeats (ITRs) (Lusby et al., 1980) . To understand the control region for the oncosuppressive activity, the AAV genome was mutated. The data indicate that the rep gene and ITRs of AAV but not the cap gene are important for AAV's inhibitory activity.
Materials and nwthods Cells
Human cervical carcinoma cell lines, HeLa and SiHa, were maintained in Dulbecco's modified Eagle medium (DMEM) and Earle's minimum essential medium (EMEM), respectively. All media were supplemented with 10% heatinactivated (56°C, 30 min) fetal calf serum, non-essential amino acids, 0.03% L-glutamine and 50 jg ml-' gentamycin. (Figure 1 ). The plasmids were purified by alkaline lysis followed by caesium chloride ultracentrifugation (Sambrook et al., 1989) .
Transfection and selection The pSV2Neo vector, or one of the recombinant plasmids described above, was transfected into cells by the lipofection method (BRL). Briefly, cells at a density of about 80% confluence in a 60 mm dish were plated one day before transfection. DNA (5 pg) and lipofectin (20 pg), each in 100 p1 of water, were mixed at room temperature for 15 min.
The lipofectin-DNA mixture was added dropwise to the cells in Opti-medium (Gibco) and incubated at 37°C for 8 h. One day later, the transfected cells in a 60 mm dish were split into five 100 mm dishes. After 24 h, 1.5 mg ml-' geneticin sulphate (G418; Gibco) at a concentration sufficient for 90% inhibition of cell growth (ID90) within 3 days was applied to select for the plasmid-harbouring cells. Ten to 14 days after selection, the survival cells formed at least 50 colonies per 100 mm dish; these colonies were then pooled as a mixture culture and used in this experiment. The ID50 (0.8 mg ml-') of G418 was subsequently employed to maintain the cells. and the lysate was passed through a glass wool column to remove the cellular DNA. The flow-through containing the viral DNA was treated with 200 pg ml-' proteinase K, extracted with phenol-chloroform, and analysed in a 1% agarose gel. The DNA was then transferred to nitrocellulose paper and hybridised with a 32P-labelled AAV probe.
Assay of turnorigenicity in vivo Tumorigenicity of cervical carcinoma cells was assayed in 4-to 6-week-old female athymic nude mice. Cells suspended in 0.1 ml of phosphate-buffered saline (PBS) were injected subcutaneously near the shoulders of the mice. The size of tumour in situ was measured in three dimensions at various times after injection. Animals were sacrificed when the tumour grew to more than 1 cm im diameter or 2 months later, whichever came first.
Results
Detection of integrated AA V DNA in HeLa and SiHa cells The AAV genome usually integrates into the host chromosome during latent infection; it can be 'rescued' and undergoes replication upon superinfection with a helper virus (Samulski et al., 1982) . To examine whether the recombinant AAV plasmids were integrated into cell chromosomes, the AAV-transfected cells were infected with Ad 5 helper viruses. Figure 2 shows that the wild-type replicative form (RF) and its dimer form were observed in both AVNeo-HeLa and AVNeo-SiHa cells (Figure 2a and b, lane 3). The replication products were absent from both parental and SVNeo-HeLa (Figure 2a , lanes 1 and 2) and from both parental and SVNeo-SiHa cells (Figure 2b , lanes 1 and 2). These results suggest that some of the transfected Figure 5 show-s that HeLa and SiHa cells had similar growth rates betx-een the parental and transfected cells (Figure 5a and b). To define the control motifs. various deletion mutants of the AAV genome were constructed as shown in Figure 1 . The in vivo tumorigenicity assay revealed that very small tumours formed in nude mice that were injected with SiHa cells transfected either with wild-type or with cap gene-deleted AAV DNA. In contrast. when the rep gene was truncated by deleting the left-end 1 kb or when both ITRs of AAV genome were removed. the oncosuppressive activity of AAV was abolished ( Figure 5) . These data clearly demonstrate that an intact rep gene and ITRs. but not an intact cap gene. are required for the oncosuppressive effect of AAV. The requirement of the rep gene or its products for oncosuppressive activity agrees with previous studies (Hermonat. 1989; Yang et al.. 1992) suppressive activity. On the other hand, ITR is needed for AAV DNA integration. Deletion of one or both ITRs may lead to an improper integration and deactivate the inhibitory function of AAV. Our results further indicate that mutation within the rep gene or ITR not only abolishes the inhibitory effect of AAV but also enhances the tumorigenicity of cancer cells. These observations point out the importance of the integrity of AAV sequence in its therapeutic applications.
The differential inhibitory effect of AAV on the tumorigenicity of HeLa and SiHa cell observed in this study has shed light on the interaction between AAV and HPV. This system can serve as a model to further elucidate the oncosuppressive mechanism of AAV, knowledge of which is a prerequisite for understanding the process of carcinogenesis and using AAV as an agent for gene therapy.
